Celldex Therapeutics Inc (CLDX)
37.92
-0.56
(-1.46%)
USD |
NASDAQ |
Apr 19, 16:00
37.92
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Cash from Operations (TTM): -107.29M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -107.29M |
| September 30, 2023 | -96.52M |
| June 30, 2023 | -112.72M |
| March 31, 2023 | -107.77M |
| December 31, 2022 | -103.73M |
| September 30, 2022 | -96.49M |
| June 30, 2022 | -77.67M |
| March 31, 2022 | -67.36M |
| December 31, 2021 | -60.91M |
| September 30, 2021 | -51.60M |
| June 30, 2021 | -47.09M |
| March 31, 2021 | -46.38M |
| December 31, 2020 | -40.40M |
| September 30, 2020 | -46.19M |
| June 30, 2020 | -45.47M |
| March 31, 2020 | -45.29M |
| December 31, 2019 | -46.42M |
| September 30, 2019 | -50.84M |
| June 30, 2019 | -54.09M |
| March 31, 2019 | -60.45M |
| December 31, 2018 | -75.24M |
| September 30, 2018 | -79.33M |
| June 30, 2018 | -89.30M |
| March 31, 2018 | -92.69M |
| December 31, 2017 | -99.93M |
| Date | Value |
|---|---|
| September 30, 2017 | -100.76M |
| June 30, 2017 | -100.35M |
| March 31, 2017 | -113.40M |
| December 31, 2016 | -113.04M |
| September 30, 2016 | -106.43M |
| June 30, 2016 | -110.27M |
| March 31, 2016 | -101.20M |
| December 31, 2015 | -98.89M |
| September 30, 2015 | -107.36M |
| June 30, 2015 | -106.16M |
| March 31, 2015 | -102.25M |
| December 31, 2014 | -101.54M |
| September 30, 2014 | -94.28M |
| June 30, 2014 | -85.14M |
| March 31, 2014 | -82.34M |
| December 31, 2013 | -67.67M |
| September 30, 2013 | -66.04M |
| June 30, 2013 | -59.53M |
| March 31, 2013 | -53.43M |
| December 31, 2012 | -49.78M |
| September 30, 2012 | -45.83M |
| June 30, 2012 | -42.94M |
| March 31, 2012 | -40.35M |
| December 31, 2011 | -35.66M |
| September 30, 2011 | -32.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-112.72M
Minimum
Jun 2023
-40.40M
Maximum
Dec 2020
-68.64M
Average
-54.09M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
| ThermoGenesis Holdings Inc | -3.721M |
| Perspective Therapeutics Inc | -36.91M |
| Electromed Inc | 4.872M |
| Xtant Medical Holdings Inc | -9.515M |
| Asensus Surgical Inc | -63.63M |